Product Information
ARTHROTEC 75 MG-200 MCG TAB is a brand product labeled by Pfizer Inc., priced at $8.4748 per EA under NDC 00025142160. Its NADAC has been published 367 times since Nov 28, 2013.
FDA first approved this application on Dec 24, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the diclofenac sodium and misoprostol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
75; 200 mg/1; ug/1
Manufacturer
Pfizer Inc.NDC
00025142160
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUM; MISOPROSTOLApproval Type
New Drug (NDA)
FDA Application
NDA020607FDA Approved
12/24/1997
TE Code
AB
On Market Since
12/24/1997
Pharmacological Classes
Price Statistics
The NADAC for ARTHROTEC 75 MG-200 MCG TAB has been published 367 times since Nov 28, 2013, and over the history we have for it it has risen 135.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.4748 per EA |
|---|---|
| All-time high | $8.5096 (Apr 15, 2026) |
| All-time low | $3.5934 (Nov 28, 2013) |
| 52-week high | $8.5096 |
| 52-week low | $8.4604 |
| Median price | $6.5733 |
| Average price | $6.5625 |
| Largest weekly change | +9.4% (Jan 6, 2016) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac sodium and misoprostol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARTHROTEC 75 MG-200 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ARTHROTEC 75 MG-200 MCG TAB, manufactured by Pfizer Inc., is $8.4748 per EA (NDC 00025142160), effective Sep 30, 2026.
How has the price of ARTHROTEC 75 MG-200 MCG TAB changed over time?
Over the history we have for it, the NADAC for ARTHROTEC 75 MG-200 MCG TAB has risen 135.8%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ARTHROTEC 75 MG-200 MCG TAB?
Since Nov 28, 2013, the NADAC for ARTHROTEC 75 MG-200 MCG TAB has ranged from a low of $3.5934 (Nov 28, 2013) to a high of $8.5096 (Apr 15, 2026), with a median of $6.5733 per EA.
Are there cheaper alternatives to ARTHROTEC 75 MG-200 MCG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DICLOFENAC-MISOPROSTOL DR 75-0.2 MG TABLET, is $0.9662 per EA — about 89% below ARTHROTEC 75 MG-200 MCG TAB.
Who manufactures ARTHROTEC 75 MG-200 MCG TAB?
ARTHROTEC 75 MG-200 MCG TAB (NDC 00025142160) is labeled by Pfizer Inc., and CMS classifies it as a brand product.